Neurocrine Biosciences (NBIX) Net margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | 7.90% | 10.4% | 13.2% | 14.5% | 16.7% | 21.6% | ||
| Changes by years, y/y, % | -31pp | +2pp | +3pp | +1pp | +2pp | -15.5% | |||
Neurocrine Biosciences. Net margin, %
Neurocrine Biosciences. Net margin, changes, pp
Neurocrine Biosciences (NBIX) Net margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Net margin, % | ? | 1.38% | 15.6% | 26.4% | 19.1% | 24.3% | 21.6% | |
| Changes by years, y/y, % | -7pp | +5pp | +5pp | +3pp | +23pp | |||
| Changes by quarters, q/q, % | -15pp | +14pp | +11pp | -7pp | +5pp | |||